ENOV
Enovis Corporation
Medical Devices · Healthcare · United States
22.81
close · 2026-10-29
value
96
cheaper than peers96
quality
27
stronger fundamentals27
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| forward P/E | 6.44× | 94 |
| price to book | 0.89× | 87 |
| price to sales | 0.66× | 86 |
| EV to EBITDA | 8.48× | 85 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 3.6% | 65 |
| revenue growth | 5.4% | 39 |
| debt to equity | 95.3% | 30 |
| return on equity | -55.3% | 27 |
4 of 4 measures available
Facts
| market cap | $1B |
| free cash flow | $206.9M |
| employees | 7,802 |
| first trade | 2008-05-08 |
| next earnings | 2026-11-05 |
| fundamentals updated | 2026-08-06 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -20.75 | -14.93 | -0.61 | -0.25 |
| free cash flow | $19.9M | -$67.2M | $12.8M | -$161.3M |
| net income | -$1.18B | -$825.5M | -$33.3M | -$13.3M |
| revenue | $2.25B | $2.11B | $1.71B | $1.56B |
| unusual items | -$1.11B | -$672.3M | -$24.7M | $110.6M |